Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Pollock

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The European Respiratory Journal|August 21, 2025
The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe chronic obstructive pulmonary disease: A randomized trial (MUSIC)Hollian Richardson, Daniela Alferes De Lima Headley, Clare Clarke, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2024
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort StudyYonghua Gao, Hollian Richardson, Alison J Dicker, et al.
Thorax|February 14, 2026
Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE studyJennifer Pollock, Jeffrey T J Huang, Morven Shuttleworth, et al.
ERJ Open Research|May 13, 2026
Bronchiectasis in Italy: an analysis of the EMBARC registryStefano Aliberti, Andrea Gramegna, Edoardo Simonetta, et al.
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2026
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registryOriol Sibila, Lidia Perea, Pierre Regis Burgel, et al.
The European Respiratory Journal|May 22, 2025
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE studyKai Xian Thng, Pei Yee Tiew, Micheál Mac Aogáin, et al.
Chest|October 26, 2024
Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis RegistryJennifer Pollock, Pieter C Goeminne, Stefano Aliberti, et al.
ERJ Open Research|July 14, 2026
The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysisMichal Shteinberg, Charles S Haworth, Jennifer Pollock, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The European Respiratory Journal|August 21, 2025
The effect of different inhaled corticosteroid and long-acting bronchodilator combinations on the airway microbiome in patients with severe chronic obstructive pulmonary disease: A randomized trial (MUSIC)Hollian Richardson, Daniela Alferes De Lima Headley, Clare Clarke, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2024
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort StudyYonghua Gao, Hollian Richardson, Alison J Dicker, et al.
Thorax|February 14, 2026
Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE studyJennifer Pollock, Jeffrey T J Huang, Morven Shuttleworth, et al.
ERJ Open Research|May 13, 2026
Bronchiectasis in Italy: an analysis of the EMBARC registryStefano Aliberti, Andrea Gramegna, Edoardo Simonetta, et al.
The Lancet. Respiratory Medicine|February 20, 2021
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort studyHolly R Keir, Amelia Shoemark, Alison J Dicker, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2026
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registryOriol Sibila, Lidia Perea, Pierre Regis Burgel, et al.
The European Respiratory Journal|May 22, 2025
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE studyKai Xian Thng, Pei Yee Tiew, Micheál Mac Aogáin, et al.
Chest|October 26, 2024
Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis RegistryJennifer Pollock, Pieter C Goeminne, Stefano Aliberti, et al.
ERJ Open Research|July 14, 2026
The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysisMichal Shteinberg, Charles S Haworth, Jennifer Pollock, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
Pageof 4